Tag: Europe
-
New Covid-19 mRNA Vaccine Trial Begins
A clinical trial is underway testing a new Covid-19 vaccine based on messenger RNA, developed by biotech company Translate Bio and drug maker Sanofi.
-
CEPI Funding SARS-CoV-2 Variant Vaccines
CEPI, an international consortium, is funding development of vaccines to protect against SARS-CoV-2 mutations, starting with B.1.351 discovered in Brazil.
-
Diagnostic Cleared for Covid-19, Other Diseases
A single diagnostic test for the virus causing Covid-19 infections and three other respiratory diseases received clearance for marketing in Europe.
-
Trial Shows Home Mosquito Device Cuts Malaria Cases
A clinical trial shows homes installed with devices that attract then kill mosquitos have fewer malaria cases than homes with standard preventions.
-
New Trial Testing Reformulated Covid-19 Vaccine
Two drug makers are beginning a clinical trial to test their reformulated vaccine against Covid-19 disease, particularly among older populations.
-
Novartis, Gates Partner on Sickle Cell Gene Therapy
Global drug maker Novartis is collaborating with the Bill and Melinda Gates Foundation to find affordable gene therapies for sickle cell disease.
-
Immune Response Shown in Alzheimer’s Vaccine
Results from a clinical trial show an experimental vaccine produces antibodies for breaking up harmful brain deposits in people with early Alzheimer’s disease.
-
Biotech, UK Govt to Design Covid-19 Variant Vaccines
A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations.
-
Cannabidiol Drug Maker Acquired in $7.2B Deal
A developer of treatments for rare neurological diseases derived from cannabis is being acquired by Jazz Pharmaceuticals in a $7.2 billion deal.
-
Covid-19 Vaccine Shown Safe, Effective in Russian Test
Interim results from a clinical trial in Russia of a two-dose vaccine show a high efficacy rate in preventing Covid-19 disease and few serious adverse effects.